Congress trades
NuVasive, Inc. (NUVA)
Free on iOS and Android.
About NuVasive, Inc.
from the company's filings and listing, as of Oct 23, 2026- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Devices
- Chief executive
- -
- Employees
- 3,000
- Listed since
- May 13, 2004
- Market value
- $2.1Blast quoted Aug 31, 2023
- Price to earnings (12 mo)
- -
- Net income per share, as reported (12 mo)
- -
- Dividend yield
- -
Earnings
6 reported quarters| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2023reported Aug 2, 2023 | $0.56 | $0.56 | $317.8M | $316.2M | EPS in lineRevenue in line |
| Q1 FY2023reported May 10, 2023 | $0.47 | $0.41 | $307.7M | $298.2M | EPS beatRevenue beat |
| Q4 FY2022reported Feb 22, 2023 | $0.43 | $0.51 | $305.4M | $311.6M | EPS missRevenue miss |
| Q3 FY2022reported Nov 9, 2022 | $0.54 | $0.53 | $295.3M | n/a | EPS beatRevenue n/a |
| Q2 FY2022reported Aug 3, 2022 | $0.47 | $0.55 | $310.5M | n/a | EPS missRevenue n/a |
| Q1 FY2022reported May 4, 2022 | $0.54 | $0.38 | $290.8M | $268.4M | EPS beatRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in NUVA
5 disclosures of 5 on record · median 13d of the 45 allowedSince the trade: the stock's move from the trade date to the last close under this ticker (Aug 31, 2023), not the member's result. Not investment advice.
| Member | Type | Action | Amount disclosed | Stock since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | -19.9%After the saleS&P 500 +2.5% · -22.4 pts vs S&P 500 | Feb 14, 2022 | Feb 27, 2022 | 13d |
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | -32.0%After the saleS&P 500 +64.1% · -96.1 pts vs S&P 500 | Feb 14, 2019 | Feb 25, 2019 | 11d |
| Lois Frankel | Stock | Purchase | $1,001 - $15,000 | -28.2%S&P 500 +61.8% · -89.9 pts vs S&P 500 | Jun 15, 2018 | Jun 22, 2018 | 7d |
| Lois Frankel | Stock | Purchase | $1,001 - $15,000 | -19.8%S&P 500 +71.6% · -91.3 pts vs S&P 500 | May 3, 2018 | May 29, 2018 | 26d |
| Lois Frankel | Stock | Purchase | $1,001 - $15,000 | -26.5%S&P 500 +70.8% · -97.3 pts vs S&P 500 | Apr 4, 2018 | Apr 27, 2018 | 23d |
Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no since-the-trade figure is computed from them.
Every Congress trade in NUVA, filterable by party, chamber, type and account.
Questions
Which members of Congress have traded NUVA?
Lois Frankel disclosed NUVA transactions in the filings shown here.
How quickly are NUVA trades disclosed?
Congressional disclosures took a median of 13 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 26, 2026.